All HHS Contracts — September 09, 2026

The firm-fixed-price structure of Magellan's $107.4M contract with HHS introduces high execution risk, as cost overruns cannot be passed to the government. The low outlayed amount ($13.2M) versus total obligation suggests potential underperformance or delayed service delivery.

Magellan Healthcare's $107.4M fixed-price contract carries high execution risk due to potential cost overruns and low outlayed amount ($13.2M).

Magellan Healthcare's reliance on this single $107.4M contract (8.7-year duration) creates revenue concentration risk if not offset by other federal awards.

HHS's continued funding of employee assistance programs (NAICS 541612) suggests stable demand for managed healthcare services, benefiting Magellan Healthcare if contract is extended or recompeted favorably.

HHS's $107.4M contract for Employee Assistance Programs demonstrates sustained civilian agency spending on workforce wellness services, with low technology intensity (NAICS 541612).

{"entity" => "Magellan Healthcare Inc.", "reason" => "Single $107.4M HHS contract with high execution risk and low outlay rate.", "trigger" => "Contract recompetition announcement or modification beyond December 2022"}

{"entity" => "Department of Health and Human Services", "reason" => "Sole-source award pattern for employee assistance programs may indicate limited competition.", "trigger" => "Future HHS EAP contract awards or set-aside policy changes"}